The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Transforming lives, raising productivity
A new report from PwC for the Association of the British Pharmaceutical Industry reveals a picture of variable and slow access to the newest, innovative treatments.Read the report from PwC on the value of medicines
Eligible NHS patients missing out on new medicines that could extend lives and add £billions to the UK economy
New research by PwC for the ABPI published today sets out the potential benefits of increased investment in clinically- and cost-effective new medicines to patients, society, and the economy.
ABPI response to 'Healthy Mum, Healthy Baby, Healthy Future' report
The 'Healthy Mum, Healthy Baby, Healthy Future' report from the University of Birmingham sets out the case for developing more medicines for use in pregnancy.
ABPI response to meeting between industry and Government on HRT supply
The ABPI welcomed today’s meeting between industry and Government on HRT supply.
ABPI welcomes appointment of Madelaine McTernan as Head of HRT Taskforce
It's important that women who need HRT can get the medicines they need
Latest blogs and events
Working together, we are all determined to create more medicines for pregnant women
Steve Hoare, the ABPI's Head of Safety and Quality, talks about how industry is trying to address the lack of medicines approved for pregnant women.
Worth the wait – The Goldacre review
Our thoughts on Professor Ben Goldacre’s “Better, broader, safer” report into health data.
Innovative medicines can bring hope to people with rare diseases – let’s get them to patients
England’s Action Plan for Rare Diseases contains important commitments to ensure that people with rare diseases get faster diagnosis, better care and timelier access to the treatments they desperately need.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 June 2022
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Key content hubs
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
The COP26 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
The #COVID19 pandemic taught us hard-learned lessons that can inform how we create a healthier, safer, more equitable world.— IFPMA (@IFPMA) May 23, 2022
10 insights from the biopharmaceutical industry from this pandemic to guide future efforts➡️https://t.co/dfikQbC4nc pic.twitter.com/2uSxFelIJP
Great to hear @annietrev launch the negotiations for a new free trade deal with Mexico. There’s real opportunity to boost life sciences exports from the U.K. if we prioritise the right policy issues. I look forward to supporting @tradegovuk 🇲🇽 🇬🇧 pic.twitter.com/wQx2knkKZ9— Richard Torbett (@TorbettR) May 20, 2022
Happy #ClinicalTrialsDay! Our Chief Executive @TorbettR celebrated at the @RoyalFreeNHS— ABPI (@ABPI_UK) May 20, 2022
We want to spread the research-active culture that they have, so that more people can be part of research and we discover the treatments of the future. 🔬🧬🧑🤝🧑 pic.twitter.com/pMb5yVkDqT